SCHEMBL9916149

SCHEMBL9916149

C=C(CC(NC(=O)c1ccc(CCc2ccc3nc(N)nc(N)c3c2)cc1)C(=O)OC)C(=O)O

nearest known ligand 0.54

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
DHFR P00374 9/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9916086 1.00 DHFR (0.54) DHFR
SCHEMBL6974948 0.94 DHFR (0.53) DHFR
SCHEMBL1128102 0.94 DHFR (0.53) DHFR
SCHEMBL1128106 0.93 DHFR (0.53) DHFR
Ch-1504 L-Isomer SCHEMBL29430181 0.91 DHFR (0.65) DHFR
Ch-1504 L-Isomer SCHEMBL1052620 0.91 DHFR (0.65) DHFR
Ch-1504 SCHEMBL7281 0.91 DHFR (0.65) DHFR
Ch-1504 SCHEMBL29430185 0.91 DHFR (0.65) DHFR
SCHEMBL6974971 0.87 DHFR (0.56) DHFR
SCHEMBL6978957 0.87 DHFR (0.56) DHFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012078708-A1 COMBINATION COMPRISING METHOTREXATE AND AN ANTIFOLATE COMPOUND CHELSEA THERAPEUTICS, INC. (US) 2012-06-14 WO disclosed
WO-2009126637-A1 ANTIFOLATE COMPOSITIONS CHELSEA THERAPEUTICS, INC. (US) 2009-10-15 WO disclosed
WO-2009126639-A1 CRYSTALLINE SALT FORMS OF ANTIFOLATE COMPOUNDS AND METHODS OF MANUFACTURING THEREOF CHELSEA THERAPEUTICS, INC. (US) 2009-10-15 WO disclosed